Long-term follow-up confirms the oncologic safety of sentinel node biopsy without axillary dissection in node-negative breast cancer patients
- PMID: 20224365
- DOI: 10.1097/SLA.0b013e3181d6115f
Long-term follow-up confirms the oncologic safety of sentinel node biopsy without axillary dissection in node-negative breast cancer patients
Comment on
-
Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study.Ann Surg. 2010 Apr;251(4):595-600. doi: 10.1097/SLA.0b013e3181c0e92a. Ann Surg. 2010. PMID: 20195151 Clinical Trial.
Similar articles
-
Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.Eur J Surg Oncol. 2007 Sep;33(7):832-7. doi: 10.1016/j.ejso.2006.11.017. Epub 2006 Dec 29. Eur J Surg Oncol. 2007. PMID: 17197151
-
Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years.Oncology. 2007;72(1-2):27-32. doi: 10.1159/000111085. Epub 2007 Nov 12. Oncology. 2007. PMID: 17998787
-
A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial.Ann Surg. 2008 Feb;247(2):207-13. doi: 10.1097/SLA.0b013e31812e6a73. Ann Surg. 2008. PMID: 18216523 Clinical Trial.
-
[Axillary lymph node recurrence after sentinel lymph node biopsy for breast cancer].J Gynecol Obstet Biol Reprod (Paris). 2007 May;36(3):253-9. doi: 10.1016/j.jgyn.2007.01.002. Epub 2007 Feb 21. J Gynecol Obstet Biol Reprod (Paris). 2007. PMID: 17317037 Review. French.
-
Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.J Surg Oncol. 2004 Mar;85(3):102-11. doi: 10.1002/jso.20022. J Surg Oncol. 2004. PMID: 14991881 Review.
Cited by
-
[Lymph node dissection in sentinel lymph node-positive malignant melanoma].Hautarzt. 2016 Oct;67(10):848-849. doi: 10.1007/s00105-016-3869-0. Hautarzt. 2016. PMID: 27573344 German. No abstract available.
-
Evaluating a Decision Aid for Improving Decision Making in Patients with Early-stage Breast Cancer.Patient. 2016 Apr;9(2):161-9. doi: 10.1007/s40271-015-0135-y. Patient. 2016. PMID: 26178202 Free PMC article.
-
De-escalation of axillary treatment in early breast cancer-a narrative review of current trials.Transl Breast Cancer Res. 2025 Jan 21;6:5. doi: 10.21037/tbcr-24-45. eCollection 2025. Transl Breast Cancer Res. 2025. PMID: 39980812 Free PMC article. Review.
-
Surgical Management of the Axilla in Breast Cancer Patients with Negative Sentinel Lymph Node: A Method to Reduce False-Negative Rate.World J Surg. 2019 Apr;43(4):1047-1053. doi: 10.1007/s00268-018-4865-6. World J Surg. 2019. PMID: 30478688
-
Preoperative MRI improves prediction of extensive occult axillary lymph node metastases in breast cancer patients with a positive sentinel lymph node biopsy.Acad Radiol. 2014 Jan;21(1):92-8. doi: 10.1016/j.acra.2013.10.001. Acad Radiol. 2014. PMID: 24331270 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical